Source: GAO survey of state pharmacy regulatory bodies, survey question 9. | GAO-17-363SP

Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.

aThe reasons states reported for not conducting joint inspections with the Food and Drug Administration (FDA) included not being asked by FDA to conduct a joint inspection, not having pharmacy inspector positions in the state, and conducting inspections separately and then sharing certain information with FDA from the inspection.